X-Energy (XE) Stock Plunges 19% This Week Despite Analyst Price Target of $57

Key Takeaways

• X-Energy shares are hovering near $25.60, retreating from an initial 56% rally following its late April IPO priced at $23 per share.
• Guggenheim set the most bullish Wall Street target at $57 with a Buy recommendation, highlighting significant upside potential.
• Morgan Stanley assigned an Overweight rating with a $41 price objective, emphasizing X-Energy’s position as a pioneer in advanced nuclear solutions.
• Jefferies adopted a Hold stance with a $28 target, citing concerns over fuel supply constraints and competitive energy technologies.
• The firm boasts a contracted pipeline of 11.5 gigawatts representing potential revenues exceeding $150 billion, counting Dow, Amazon, and Centrica among its clients.

X-Energy ($XE) launched its public offering at $23 per share in late April, significantly exceeding the anticipated $16–$19 pricing range, and secured over $1 billion in capital. Shares initially jumped 56% during the first two trading sessions but have since corrected to approximately $25.60.

X-Energy, Inc. Class A Common Stock, XE

The expiration of the IPO quiet period on Tuesday unleashed multiple analyst reports. The majority leaned bullish.

The company generated $94 million in revenue during the previous year while recording a $390 million net loss and maintaining a negative gross margin of 71%. In practical terms, X-Energy remains in a pre-commercial phase.

Nonethstanding these financials, Guggenheim’s Joseph Osha initiated coverage with a Buy recommendation and established a $57 price objective — marking the most optimistic Street forecast. Osha identified three catalysts: corporate decarbonization initiatives, cross-party political backing for nuclear power, and growing power requirements from AI data infrastructure.

The firm’s project pipeline encompasses approximately 11.5 gigawatts distributed across 144 reactor units, translating to more than $150 billion in prospective revenue. Major clients include Dow, Amazon, and Centrica.

Morgan Stanley launched coverage with an Overweight designation and $41 target price. Analyst David Arcaro characterized X-Energy as a “first mover in next-generation nuclear technology.” He emphasized the organization’s asset-light strategy, focused on repeating fuel supply and maintenance agreements instead of direct reactor ownership.

Morgan Stanley projects X-Energy will achieve EBITDA profitability by 2030, commission its initial facility in 2033, and expand capacity to 20 gigawatts by 2040.

Skeptical Perspectives

Not all analysts share the enthusiasm. Jefferies adopted a more reserved position, launching coverage with a Hold rating and $28 price target — representing merely 9% appreciation from present levels.

The investment bank identified fuel availability challenges as a significant concern, alongside emerging competition from more affordable and quicker-to-deploy options including solar, natural gas, and geothermal technologies.

Jefferies analyst Julien Dumoulin-Smith stated that “further upside from here will require progress on additional Amazon/Centrica customer progress, commercialization success, and supply chain visibility.”

The firm additionally observed that initial commercial operations remain more than half a decade away, introducing considerable uncertainty into valuation frameworks.

Based on InvestingPro’s assessment, the shares appear elevated at present pricing. The equity has declined 19% during the past week and is exchanging hands close to its 52-week floor of $25.06.

Extended Timeline to Commercialization

UBS and JPMorgan likewise launched coverage reports, with UBS emphasizing the company’s comprehensive reactor, fuel, and service ecosystem as a competitive advantage. JPMorgan issued an Overweight rating, underscoring the substantial 11.5 gigawatt contracted backlog.

X-Energy’s public offering attracted demand exceeding available shares by more than 15-fold, capturing attention from buy-and-hold funds, sector specialists, and pre-IPO stakeholders.

Shares advanced 3% during early Tuesday trading session following the release of analyst coverage.